In summer 2019, the Congressional Appropriations Committee voted to reinstate a rider to the Consolidated Appropriations Act that prohibits the FDA from reviewing clinical applications in which a human embryo would be intentionally created or modified to include a heritable genetic modification. Prior to this vote,...
Tag: Mitochondrial Replacement Therapy
Public Comments to Singapore’s Bioethics Advisory Committee on Mitochondrial Replacement Therapy
posted by: Katherine Drabiak, J.D.
July 26, 2018
In the Spring of 2018, Singapore issued a call for Public Comments on the topic of whether it should repeal the country’s current prohibition against germline modification of embryos and permit an exception for Mitochondrial Replacement Therapy. See the story here and here. ...